Extending trastuzumab-coated immunoliposome to HER2 negative breast cancer models : a proof of concept study - Archive ouverte HAL
Poster Communications Year : 2018

Extending trastuzumab-coated immunoliposome to HER2 negative breast cancer models : a proof of concept study

Abstract

Want to know more?

Domains

Micro and nanotechnologies/Microelectronics Cancer
Fichier principal
Vignette du fichier
Rodallec_GPCO 2018.pdf (1.54 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Anne Rodallec  : Connect in order to contact the contributor

https://hal.science/hal-04727223

Submitted on : Wednesday, October 9, 2024-9:41:02 AM

Last modification on : Tuesday, October 15, 2024-3:10:20 AM

Download

Dates and versions

hal-04727223 , version 1 (09-10-2024)

Identifiers

  • HAL Id : hal-04727223 , version 1

Cite

Anne Rodallec, Guillaume Sicard, Sarah Giacometti, Stéphane Robert, Florian Correard, et al.. Extending trastuzumab-coated immunoliposome to HER2 negative breast cancer models : a proof of concept study. Journées GPCO (Le Groupe de Pharmacologie Clinique Oncologique), Nov 2018, Villejuif, France. ⟨hal-04727223⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM CNRS UNIV-AMU INP INP-GLIOME PHARMA-AMU CRCM INRAE INRAEPACA
19 View
7 Download

Share

More